Mengyu Yao , Miaomiao Xia , Jinlong Li , Huina Dong , Liping Du , Dawei Zhang
{"title":"Enhancing riboflavin production by modulating the expression of the rib operon in Bacillus subtilis","authors":"Mengyu Yao , Miaomiao Xia , Jinlong Li , Huina Dong , Liping Du , Dawei Zhang","doi":"10.1016/j.procbio.2024.11.020","DOIUrl":null,"url":null,"abstract":"<div><div>Riboflavin is an essential vitamin for humans and animals, with its annual demand experiencing a consistent upward trajectory. In recent years, newly constructed riboflavin producing strains are difficult to reach the level of industrial strains. Therefore, developing competitive strains is crucial for advancing the riboflavin industry. The expression level of the <em>rib</em> operon is strongly correlated with riboflavin biosynthesis. The strain S12, which overexpressed the <em>rib</em> operon of <em>B. subtilis</em> using plasmids with approximately 8 copies, achieved a 53.9 % increase in riboflavin biosynthesis during shake-flask fermentation. However, the strain cannot grow normally in a 7.5-L bioreactor. The expression of <em>rib</em> operon may have competed with cell growth for GTP or produced toxic intermediate ArP. Therefore, the strain S16 replaced <em>ribA</em> in <em>rib</em> operon with a monofunctional DHBP synthase, increased 20 % of riboflavicn production in a 7.5-L bioreactor. Furthermore, the strain S24, which overexpressed the <em>rib</em> operon using the phase-dependent promoter P<sub><em>yqgZ</em></sub>, attained a riboflavin production of 29 g/L in a 7.5-L bioreactor, achieving the highest reported riboflavin production to date. This study reports for the first time using the phase-dependent promoter for overexpression of <em>rib</em> operon, effectively regulated the relationship between cell growth and riboflavin production.</div></div>","PeriodicalId":20811,"journal":{"name":"Process Biochemistry","volume":"148 ","pages":"Pages 139-149"},"PeriodicalIF":3.7000,"publicationDate":"2024-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Process Biochemistry","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S135951132400374X","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Riboflavin is an essential vitamin for humans and animals, with its annual demand experiencing a consistent upward trajectory. In recent years, newly constructed riboflavin producing strains are difficult to reach the level of industrial strains. Therefore, developing competitive strains is crucial for advancing the riboflavin industry. The expression level of the rib operon is strongly correlated with riboflavin biosynthesis. The strain S12, which overexpressed the rib operon of B. subtilis using plasmids with approximately 8 copies, achieved a 53.9 % increase in riboflavin biosynthesis during shake-flask fermentation. However, the strain cannot grow normally in a 7.5-L bioreactor. The expression of rib operon may have competed with cell growth for GTP or produced toxic intermediate ArP. Therefore, the strain S16 replaced ribA in rib operon with a monofunctional DHBP synthase, increased 20 % of riboflavicn production in a 7.5-L bioreactor. Furthermore, the strain S24, which overexpressed the rib operon using the phase-dependent promoter PyqgZ, attained a riboflavin production of 29 g/L in a 7.5-L bioreactor, achieving the highest reported riboflavin production to date. This study reports for the first time using the phase-dependent promoter for overexpression of rib operon, effectively regulated the relationship between cell growth and riboflavin production.
期刊介绍:
Process Biochemistry is an application-orientated research journal devoted to reporting advances with originality and novelty, in the science and technology of the processes involving bioactive molecules and living organisms. These processes concern the production of useful metabolites or materials, or the removal of toxic compounds using tools and methods of current biology and engineering. Its main areas of interest include novel bioprocesses and enabling technologies (such as nanobiotechnology, tissue engineering, directed evolution, metabolic engineering, systems biology, and synthetic biology) applicable in food (nutraceutical), healthcare (medical, pharmaceutical, cosmetic), energy (biofuels), environmental, and biorefinery industries and their underlying biological and engineering principles.